-transparent.png){kind=logo}
Since 1978 several cases of chloroquine-resistant falciparum malaria have been reported from East Africa (Petterson et al., 1981). Sulfadoxine-pyrimethamine (Fansidar) has been advised by W.H.O. (Wkly Epidem. Rec., 1982) for therapeutic management of these patients. We describe here a non-immune female expatriate from Tanzania suffering from falciparum malaria, which was resistant to chloroquine (R II-III). She had been working as a medical technician in the Morogoro region, a hyperendemic malarious area. After being treated with Fansidar she was transferred to the Netherlands where a recrudescence developed. She was then treated with a combination of quinine and tetracycline which resulted in the clearance of the parasitaemia. This is the third report of Fansidar-resistant falciparum malaria from Tanzania in the Netherlands (de Geus et al., 1982; Timmermans et al., 1982).
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
January 1982,
Tropical and geographical medicine,
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
September 1983,
Tropical and geographical medicine,
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
June 1981,
The Medical journal of Australia,
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
January 1986,
The American journal of tropical medicine and hygiene,
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
December 1988,
Deutsche medizinische Wochenschrift (1946),
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
August 1985,
Lancet (London, England),
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
March 1980,
Schweizerische medizinische Wochenschrift,
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
October 1986,
The Journal of tropical medicine and hygiene,
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
April 1981,
Ugeskrift for laeger,
M P Vleugels, and
J C Wetsteyn, and
J H Meuwissen
September 1979,
Lancet (London, England),
